A pro-life medical group, AAPLOG, is urging New York Gov. Kathy Hochul to reverse a law protecting the identities of healthcare providers who prescribe the abortion pill mifepristone, citing patient safety concerns and the need for follow-up care. The group emphasizes the risks and complications associated with drug-induced abortions, calling for reconsideration of the law to ensure accessibility and proper medical oversight. Hochul signed the legislation following the indictment of a New York physician in Louisiana, allowing providers’ names to be omitted from abortion pill packaging, but AAPLOG contends this could hinder patient care and safety.
Full Article
Monthly weight loss drug helps people lose 20% of body weight, trial finds
Amgen's monthly weight loss drug MariTide demonstrated a 20% average body weight reduction in a phase 2 trial, positioning it as a potential competitor in the GLP-1 market dominated by Novo Nordisk and Eli Lilly. With added benefits like improved A1c levels and cardiovascular risk factors, MariTide aims for a phase 3 trial, highlighting advancements in diabetes and weight loss treatments. Need More Context? 🔎
Read more